Financial News

Financial Report: Quintiles

Product Development segment up 13% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Quintiles 2Q Revenues: $1.2 billion (+9%) 2Q Earnings: $150.7 million (-5%) Comments: Service revenues grew 8% in the quarter with Product Development segment up 13% to $890.1 million and the Integrated Healthcare Services segment down 6%. Net new business grew 24% compared to the same period last year to $1.64 billion, representing a book-to-bill ratio of 1.41 in the quarter ended June 30, 2016. Second quarter net new business contributed to an ending backlog of $12.5 billion at June 3...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters